Biodesix market cap BDSX
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Nov 2, 2026
- $229.8M
- Highest close in our data
- $743.2M
- Jan 2021
Biodesix is worth $229.8M at the close on Nov 2, 2026, at $21.78 a share.
That is up 274% over the last year and up 15% over five years.
Its highest close in our data was $743.2M in Jan 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $229.8M | $43.4M | $308.1M | +324% |
| 2025 | $54.3M | $36.7M | $215.3M | −75% |
| 2024 | $215.3M | $119.2M | $284.5M | +29% |
| 2023 | $166.5M | $75.8M | $167.4M | +72% |
| 2022 | $96.8M | $40.4M | $145.9M | −32% |
| 2021 | $142.9M | $124.3M | $743.2M | −73% |
| 2020 | $535.1M | $417.8M | $535.1M | n/a |
Against its peers
Companies in Healthcare nearest Biodesix's size, closest first, today.
| Company | Market cap |
|---|---|
| BDSXBiodesix | $229.8M |
| UTMDUtah Medical Products | $224.6M |
| ELMDElectromed | $223.9M |
| NATRNatures Sunshine Products | $211.5M |
| PLXProtalix BioTherapeutics | $206.3M |
| INFUInfuSystem | $275.7M |
| PDEXPro DEX | $184.5M |
| CYHCommunity Health Systems | $296.2M |
| EMBCEmbecta | $350.7M |
| VMDViemed Healthcare | $359.6M |
| CRMDCorMedix | $420.1M |
| Peer median | $250.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Biodesix
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.